Scottsdale, AZ9 Active Studies

Pulmonary Embolism Clinical Trials in Scottsdale, AZ

Find 9 actively recruiting pulmonary embolism clinical trials in Scottsdale, AZ. Connect with local research sites and explore new treatment options.

9
Active Trials
9
Sponsors
6,869
Enrolling

Recruiting Pulmonary Embolism Studies in Scottsdale

RecruitingScottsdale, AZNCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....

2,100 participants
Pfizer
View Study Details
RecruitingScottsdale, AZNCT07104383

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic ef...

1,100 participants
Viking Therapeutics, Inc.
View Study Details
RecruitingScottsdale, AZNCT06628908

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

1,100 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingScottsdale, AZNCT07088068

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...

723 participants
Sanofi
View Study Details
RecruitingScottsdale, AZNCT05723198

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 ye...

595 participants
Eli Lilly and Company
View Study Details
RecruitingScottsdale, AZNCT06481891

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compar...

500 participants
Lexicon Pharmaceuticals
View Study Details
RecruitingScottsdale, AZNCT04939090

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine...

360 participants
Alliance for Clinical Trials in Oncology
View Study Details
RecruitingScottsdale, AZNCT04787042

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

316 participants
Simcha IL-18, Inc.
View Study Details
RecruitingScottsdale, AZNCT06018428

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. P...

75 participants
Q32 Bio Inc.
View Study Details

About Pulmonary Embolism Clinical Trials in Scottsdale

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 9 pulmonary embolism clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 6,869 participants. Research is being sponsored by Pfizer, Viking Therapeutics, Inc., Vertex Pharmaceuticals Incorporated and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Scottsdale — FAQ

Are there pulmonary embolism clinical trials in Scottsdale?

Yes, there are 9 pulmonary embolism clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 9 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov